. . . . . . . . . . . . . . . . . . . . . . "cat(p(RGD:Parp1)) -> bp(MESHPP:Apoptosis)" . "cat(p(RGD:Sirt1)) -| (cat(p(RGD:Parp1)) -> bp(MESHPP:Apoptosis))" . "Approximately 61,000 statements." . "Copyright (c) 2011-2012, Selventa. All rights reserved." . "BEL Framework Large Corpus Document" . . "20131211" . "The beneficial effect of NAD repletion was seen, however, only when Sir2alpha was intact." . . "Selventa" . . . . "2014-07-03T14:32:51.161+02:00"^^ . . .